Loading clinical trials...
Loading clinical trials...
This study is designed to assess neurobehavioral performance, as well as genetic and other physiological changes associated with variations in timing and quantity of sleep.
During a 1.5 week inpatient laboratory protocol, subjects will undergo one of four parallel sleep conditions. Subjects will be randomly assigned to each condition group. During their time in the laboratory, biological samples (e.g., blood) will be collected for genetic and other analyses, and sleep quantity and quality will be monitored. Additionally responses on neurobehavioral tests and surveys will be monitored for differences among the groups.
Age
20 - 45 years
Sex
ALL
Healthy Volunteers
Yes
Brigham and Women's Hospital
Boston, Massachusetts, United States
FAA Civil Aerospace Medical Institute
Oklahoma City, Oklahoma, United States
Start Date
August 25, 2020
Primary Completion Date
September 12, 2023
Completion Date
September 12, 2023
Last Updated
September 29, 2023
59
ACTUAL participants
Controlled sleep
BEHAVIORAL
Lead Sponsor
Civil Aerospace Medical Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07084701